LifePoint Health, Inc.
LifePoint Health, Inc. Fundamental Analysis
LifePoint Health, Inc. (LPNT) shows weak financial fundamentals with a PE ratio of 25.32, profit margin of 1.41%, and ROE of 4.63%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 26.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze LPNT's fundamental strength across five key dimensions:
Efficiency Score
WeakLPNT struggles to generate sufficient returns from assets.
Valuation Score
ModerateLPNT shows balanced valuation metrics.
Growth Score
WeakLPNT faces weak or negative growth trends.
Financial Health Score
ModerateLPNT shows balanced financial health with some risks.
Profitability Score
WeakLPNT struggles to sustain strong margins.
Key Financial Metrics
Is LPNT Expensive or Cheap?
P/E Ratio
LPNT trades at 25.32 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, LPNT's PEG of 0.25 indicates potential undervaluation.
Price to Book
The market values LifePoint Health, Inc. at 1.16 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -4.17 times EBITDA. This is generally considered low.
How Well Does LPNT Make Money?
Net Profit Margin
For every $100 in sales, LifePoint Health, Inc. keeps $1.41 as profit after all expenses.
Operating Margin
Core operations generate 4.37 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.63 in profit for every $100 of shareholder equity.
ROA
LifePoint Health, Inc. generates $1.63 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.07 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.32
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.25
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.16
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.29
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.70
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How LPNT Stacks Against Its Sector Peers
| Metric | LPNT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.32 | 28.36 | Better (Cheaper) |
| ROE | 4.63% | 751.00% | Weak |
| Net Margin | 1.41% | -46319.00% (disorted) | Weak |
| Debt/Equity | 1.29 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.70 | 4.13 | Neutral |
| ROA | 1.63% | -17844.00% (disorted) | Weak |
LPNT outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews LifePoint Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation